Poor choice of primary outcome in a clinical trial of pirfenidone in patients with IPF [3]

American Journal of Respiratory and Critical Care Medicine

Volumn 172, Issue 9, 2005, Pages 1229-1230

  Raghu, Ganesh ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIRFENIDONE;

ANALYSIS OF VARIANCE; ARTERIAL OXYGEN SATURATION; CLINICAL TRIAL; CONSENSUS; DISEASE EXACERBATION; EXERCISE TEST; FIBROSING ALVEOLITIS; HUMAN; JAPAN; LETTER; LUNG FIBROSIS; PRIORITY JOURNAL;

EID: 30344477391     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/ajrccm.172.9.952     Document Type: Letter

References (10)

1. du Bois RM. Is idiopathic pulmonary fibrosis now treatable? [editorial] Am J Respir Crit Care Med 2005;171:939-940.
2. Azuma A, Nukiwa T, Tsuboi E, Suga M, Abe S, Nakata K, Taguchi Y, Nagai S, Itoh H, Shi M, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005;171:1040-1047.
3. Kondoh Y, Tanigushi H, Kawabata Y, Yokoi T, Suzuki K, Takagi K. Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathologic findings in three cases. Chest 1993;103:1808-1812.
4. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004;350:125-133.
5. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr, Flaherty KR, Schwartz DA, Noble PW, Raghu G, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005;142:963-967.
6. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, Murray S, Kazerooni EA, Gross BH, Lynch JP III, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003;168:1084-1090.
7. Hallstrand TS, Boitano LJ, Johnson WC, Spada CA, Hayes JG, Raghu G. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J 2005;25:96-103.
8. Boitano LJ, Hallstrand T, Freudenberger T, Raghu G. Timed walk test-a modified version of the six-minute walk test accurately reflects lung function abnormalities in patients with idiopathic pulmonary fibrosis. Chest 2000;118:96S-97S.
9. Eaton T, Young P, Milne D, Wells AU. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia.AmJ Respir Crit Care Med 2005;171:1150-1157.
10. Tsuboi E, Kawabata M, Kishi K, Narui K, Homma S, Nakatani T, Nakata K. Treadmill six-minute walk tests in patients with idiopathic pulmonary fibrosis. The Annual Report by Study Group of Ministry of Health and Welfare for Diffuse Lung Disease; 2000. pp.132-135. Available from http://mhlw-grants.niph.go.jp/ niph/search/.